Introduction
Dead cells can behave like damage-associated molecular patterns (DAMPs) and activate the innate and adaptive arms of the immune system (Kono and Rock, 2008) . Moreover, DAMPs are produced after brain ischemia and may affect the clinical course and outcome of patients with acute stroke (Iadecola and Anrather, 2011; Chamorro et al., 2012) . Brain-derived antigens may leave the central nervous system (CNS) via the blood stream (Hochmeister et al., 2010) or via the bulk flow of intracranial fluids along cranial nerves and perivascular spaces of brain cortical arteries and arterioles (Bradbury et al., 1981; Weller et al., 2008) . After stroke, brain-derived antigens and antigen presenting cells (APCs) can reach the brain-draining secondary lymph nodes, such as the cervical lymph nodes (CLN) (Harling-Berg et al., 1999; deVos et al., 2002; van Zwam et al., 2008) and the palatine tonsils (PT) (Planas et al., 2012) . At these lymph nodes, brain derived-antigens loaded onto MHC molecules could be presented to T cells, and subsequently activate them (von Andrian and Memple, 2003) . Interestingly, it has been argued that immune responses originating in the CLN have a Th2 phenotype to facilitate tolerogenic mechanisms against further inflammation and brain injury (Harling-Berg et al., 1999) .
Heat shock protein 70 (Hsp-70) is a molecular chaperone that may behave as a danger signal under certain conditions (Basu et al., 2000) . While Hsp-70 expression is virtually undetectable in the brain under physiological conditions, it is strongly induced in neurons following brain ischemia (Nowak et al., 1990; Kinouchi et al., 1993; Sharp et al., 1993; Planas et al., 1997; de la Rosa et al., 2013) . Robust experimental evidence supports the hypothesis that Hsp-70 induction is protective in brain ischemia (Nowak and Jacewicz, 1994; Yenari et al., 1998 Yenari et al., , 1999 Yenari, 2002) , and that these neuroprotective effects may be due to various mechanisms including a more efficient formation, folding and assembly of nascent proteins, a better refolding and stabilization of damaged peptides, and some anti-apoptotic effects (Yenari et al., 1999; Hartl and Hayer-Hartl, 2002; Yenari et al., 2005) . Likewise, Hsp70.1 knockout mice show larger infarct volumes after transient focal ischemia (Lee et al., 2001a) , while transgenic mice constitutively expressing the human (Plumier et al., 1997; Rajdev et al., 2000) or rat (Tsuchiya et al., 2003) inducible Hsp-70, and mice overexpressing Hsp-70 in astrocytes (Xu et al., 2010) , are protected against ischemic brain damage. Hsp-70 overexpression, however, was not protective in certain models of permanent focal (Lee et al., 2001b) or global (Olsson et al., 2004 ) ischemia. In ischemia/reperfusion, virally delivered Hsp-70 (Badin et al., 2006) or intravenous administration of cell penetrating recombinant Journal of Neuroimmunology 270 (2014) 67-74 
